SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Statement

19 May 2008 13:30

RNS Number : 7780U
Flomerics Group PLC
19 May 2008
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATESAUSTRALIACANADA OR JAPAN

FOR IMMEDIATE RELEASE

19th May 2008

FLOMERICS GROUP PLC

Statement re: Posting of Offer Document following Unsolicited Offer

 

 

The Board of Directors of Flomerics Group PLC ("Flomerics" or the "Company") notes the statement by Mentor Graphics, Inc. ("Mentor") that it has posted an offer document to Flomerics shareholders in respect of its unsolicited offer for all the outstanding shares and stock options in Flomerics at a price of 104 pence per share payable in cash (the "Offer"). 

 

The Board of Directors of Flomerics continues to believe the Offer materially undervalues the Company and is actively engaged in assessing other alternatives available to the Company, including potential interest expressed by a number of other parties, which are the subject of ongoing discussions. Shareholders are therefore strongly urged to ignore any documents or announcements that may be made or issued by Mentor or its advisers and not to sell their valuable Flomerics shares.

David Mann, Chairman of Flomerics commented: "We have previously stated that the Offer, which is unsolicited, has been considered by the Board of Flomerics, in conjunction with its independent adviser, and we have unanimously concluded that it does not reflect the true value of Flomerics shares. As such, the Offer does not carry the recommendation of the Flomerics Board of Directors as we do not believe it is in the best interests of Flomerics shareholders." 

The Board of Directors intends to write to its shareholders in due course to explain its current position with regard to the Mentor Offer.

Any discussions with other interested parties continue to be at an early stage and there can be no certainty that an alternative offer will be forthcoming. However, shareholders are strongly recommended to take no action at this stage. A further announcement will be made in due course.

 

Enquiries: 

 

Flomerics Group PLC

Gary Carter

Keith Butcher

Tel: 020 8487 3000

Jefferies International Ltd (Financial adviser to Flomerics)

Andres Pieczanski

Sarah McNicholas

Tel: 020 7029 8000

Oriel Securities Limited (Nominated Adviser and Corporate Broker to Flomerics)

Andrew Edwards

Michael Shaw

Tel: 020 7710 7600

Citigate Dewe Rogerson

Ginny Pulbrook

Seb Hoyle

Tel: 020 7638 9571

 

Jefferies International Limited ("Jefferies International"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Jefferies International or for giving advice in relation to such matters.

Oriel Securities Limited ("Oriel Securities"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Oriel Securities or for giving advice in relation to such matters.

 

 Dealing Disclosure Requirements 

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Flomerics, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Nestor, they will be deemed to be a single person for the purpose of Rule 8.3. 

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Flomerics by a potential offeror or by Flomerics, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction. 

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk. 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

 

Terms in quotation marks are defined in the Code, which can also be found on the Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPGUUAPAUPRGPB
Date   Source Headline
31st Jan 20197:00 amRNSTrading Update & Notice of Full Year Results
29th Jan 20197:00 amRNSHolding(s) in Company
23rd Jan 20199:42 amRNSChange of Registered Office
27th Nov 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSDeferred Consideration and Total Voting Rights
23rd Oct 20187:00 amRNSTrading update - nine month period ended 30.9.18
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20187:00 amRNSHolding(s) in Company
1st Oct 20183:03 pmRNS2018 Half-year Report Published
27th Sep 201812:06 pmRNSDirector/PDMR Shareholding
24th Sep 201810:02 amRNSDirector/PDMR Shareholding
20th Sep 20186:04 pmRNSDirector/PDMR Shareholding
20th Sep 20181:20 pmRNSDirector/PDMR Shareholding
18th Sep 20187:01 amRNSHalf-year Report
18th Sep 20187:00 amRNSDirectorate Changes
24th Aug 20181:57 pmRNSHolding(s) in Company- updated
23rd Aug 20183:53 pmRNSHolding(s) in Company
24th Jul 20186:24 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSGroup Trading Update & Notice of HY Results
6th Jun 201811:10 amRNSResult of AGM
6th Jun 20187:00 amRNSAGM Statement
21st May 20183:46 pmRNSHolding(s) in Company
14th May 20187:00 amRNSOption Exercise and Director's Dealings
4th May 20183:30 pmRNS2017 Annual Report - year ended 31 December 2017
27th Apr 20185:51 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSHolding(s) in Company
17th Apr 20187:01 amRNSQ1 2018 Quarter Results
17th Apr 20187:00 amRNSFinal statement of results - year ended 31.12.17
9th Apr 201811:35 amRNSHolding(s) in Company
3rd Apr 201811:24 amRNSResult of General Meeting & Total Voting Rights
26th Mar 201812:18 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSFlowtech Chairman receives FTSE AIM NED award
20th Mar 20183:16 pmRNSCompletion of the acquisition of Balu Limited
19th Mar 20182:39 pmRNSHolding(s) in Company
19th Mar 201811:52 amRNSOption Exercise and Director's Dealings
15th Mar 20187:00 amRNSPosting of circular
14th Mar 20187:00 amRNSAcquisition of Balu Ltd - Placing to raise £11m
1st Mar 201812:03 pmRNSHolding(s) in Company
26th Feb 201812:51 pmRNSHolding(s) in Company
23rd Jan 20187:00 amRNS2017 Trading Update & Notice of Full-Year Results
19th Oct 20171:54 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSQ3 Group Trading Update
12th Oct 20177:00 amRNSAcquisition of Group HES, New Division established
27th Sep 20173:57 pmRNSSilver award winner for 2017 online Annual Report
22nd Sep 20172:48 pmRNSHolding(s) in Company
19th Sep 20176:36 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSOrganic & acquisition strategy underpins future
7th Sep 20173:38 pmRNSFLOWTECH EXPANDS ITS FOOTPRINT IN EUROPE
10th Jul 20177:00 amRNSGroup Trading update & Notice of HY results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.